^
Association details:
Biomarker:No biomarker
Cancer:Hodgkin Lymphoma
Regimen:ICE (carboplatin + etoposide IV + ifosfamide)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Hodgkin Lymphoma: CHL, Second-line option added:...ICE (ifosfamide, carboplatin, etoposide)